EAPS

myTomorrows Launches TrialSearch AI to Deliver Access to Comprehensive, Unbiased Clinical Trial Information Worldwide

Retrieved on: 
Tuesday, April 25, 2023
Registry, LLM, GPT, Physician, Clinical trial, Cancer, Research, OpenAI, EAPS, MD, Patient, European, Artificial intelligence, Caregiver, Pharmaceutical industry, Medical device, Dietary supplement

“Our team of researchers and developers designed TrialSearch AI to bring greater speed, transparency, and accuracy to the complex, time-consuming task of manually searching for clinical trials” said Michel van Harten, MD, CEO at myTomorrows.

Key Points: 
  • “Our team of researchers and developers designed TrialSearch AI to bring greater speed, transparency, and accuracy to the complex, time-consuming task of manually searching for clinical trials” said Michel van Harten, MD, CEO at myTomorrows.
  • This input is used to identify relevant clinical trial eligibility criteria and to provide a list2 of clinical trials and, if suitable, expanded access programs, that may be appropriate for the patient.
  • For more information about TrialSearch AI, or to join the wait list to trial the tool, visit webpage.
  • 1 myTomorrows searches for clinical trials and other pre-approval options exclusively on clinicaltrials.gov and the European Union’s Clinical Trials Register, the two global and trusted clinical trial databases.

GenSight Biologics Announces Presentation of LUMEVOQ® Efficacy and Safety Data from Early Access Programs for ND4-LHON Patients at NANOS 2023

Retrieved on: 
Wednesday, March 15, 2023
Health, Genetics, Research, Science, Pharmaceutical, Optical, Biotechnology, Multimedia, Injection, EAP, Eye, MD, EAPS, Hospital, Neuro-ophthalmology, LHON, ISIN, Patient, Annual Meetings of the International Monetary Fund and the World Bank Group, ND4, Safety, Intravitreal injection, Pharmaceutical industry, Medical imaging, Mendelian traits in humans, Ophthalmology, Euronext

View the full release here: https://www.businesswire.com/news/home/20230314006021/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230314006021/en/
    Figure 1: Global evolution of mean BCVA over two years in patients who received LUMEVOQ® in early access programs.
  • Individual data from 45 out of the 63 patients who had passed the one-year post-treatment point and performed their one-year visit were pooled and analyzed1.
  • The data confirmed the efficacy and safety profile of LUMEVOQ® in a real-world setting.
  • Figure 1: Global evolution of mean BCVA over two years in patients who received LUMEVOQ® in early access programs.

Talkspace Launches First-of-its-Kind Portal Dedicated to Employee Mental Health Resources

Retrieved on: 
Thursday, February 16, 2023
Women, Other Health, Seniors, Parenting, Men, Telecommunications, Software, Human Resources, Mental Health, Consumer, Professional Services, Technology, General Health, Public Relations, Investor Relations, Marketing, Advertising, Health, Communications, EQ, EAPS, Enterprise, Workplace, HR, Mental, Mindfulness, Ecosystem, Emotional intelligence, Employee assistance program, Learning, Emotional Intelligence, Unconscious, Mental health, Nursing, Talkspace

The innovative new portal is designed to provide people leaders and HR teams with access to a full library of clinical resources and a simplified "one-click" system that allows them to promote mental wellbeing and drive utilization of the company’s available mental health services, including their Employee Assistance Programs (EAPs) and Talkspace services.

Key Points: 
  • The innovative new portal is designed to provide people leaders and HR teams with access to a full library of clinical resources and a simplified "one-click" system that allows them to promote mental wellbeing and drive utilization of the company’s available mental health services, including their Employee Assistance Programs (EAPs) and Talkspace services.
  • Talkspace Engage organizes mental health and wellbeing resources into a single library on the platform, while making it easy for people teams to download or share materials directly from the platform.
  • As a preferred virtual therapy provider for employers across the U.S., Talkspace is redefining workplace mental health by creating best-in-class user-experiences at the enterprise level.
  • For more information on Talkspace’s enterprise offering or to request a demo of Talkspace Self-Guided and Talkspace Engage, visit https://business.talkspace.com .

International SOS: Workplace Health Strategies Can Reduce Cancer Risk

Retrieved on: 
Friday, February 3, 2023
Other Travel, Human Resources, Oncology, Health, Travel, Other Transport, Professional Services, Transport, Diet, World Cancer Day, Smoking, International SOS, Morale, Breast, Medicine, Molina Healthcare, EAPS, Workplace, Human, Education, Workforce, Culture, Death, Policy, International, Exercise, Tobacco, Public, Introduction, Dietary supplement, Management, Cancer

The workplace can be a key setting for implementing efforts to reduce cancer risk among the working population.

Key Points: 
  • The workplace can be a key setting for implementing efforts to reduce cancer risk among the working population.
  • The workplace may also inadvertently lead to inactivity and poor eating habits3, both of which are risk factorsfor cancer.
  • It is vital for organisations to promote cancer prevention in their workplace and take an integrated and comprehensive approach by providing education and adopting an organisational culture through policies that influence cancer risk.
  • Simple workplace changes can reduce cancer risk such as providing healthy food options, promoting smoking cessation programmes and creating a culture of safe alcohol use.”
    International SOS outlines some strategies to mitigate cancer risk for employees and how organisations can strengthen their workplace support:
    1.

Electroactive Polymer Global Market Report 2022: Featuring Solvay, Parker Hannifin, Novasentis, The Heraeus Group & More

Retrieved on: 
Monday, January 23, 2023
Actuator, Tissue engineering, Growth, National Council, Textile, Electroactive polymer, EAPS, Electronics, Speciality chemicals, 3D printing

Global Electroactive Polymer Market is projected to grow at an impressive CAGR during the forecast period due to increase in end use industries.

Key Points: 
  • Global Electroactive Polymer Market is projected to grow at an impressive CAGR during the forecast period due to increase in end use industries.
  • In 2021, the market value of the Indian textile industry was worth USD 223 billion.
  • Due to the presence of numerous significant manufacturers, APAC is likely to continue to play an essential role in the electroactive polymer market over the forecast period.
  • Remarkable advances in upgrading the actuation strain of Novel Applications such as microfluidic systems and tissue engineering have also emerged, enabling the demand for Actuators resulting in the forecasted growth of the Global Electroactive Polymer Market.

KemPharm Issues Letter to Shareholders

Retrieved on: 
Tuesday, January 24, 2023
Disease, Narcolepsy, Idiopathic hypersomnia, IH, Food, Safety, Somnolence, Arimoclomol, CNS, Cognition, KMPH, Acquisition, Pediatrics, Neurodegeneration, Niemann–Pick disease, Special access program, Glycogen storage disease, Therapy, Death, European Medicines Agency, Lipid, NDA, Child development stages, New Drug Application, Central nervous system, Letter, SDX, Learning, Patient, RICH, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, FDA, Methylphenidate, Interim, NPC, Investment, Growth, Speech, EAPS, Cell, Degenerative disease, Brain, Pharmaceutical industry, Management, Risk management, Shareholder

CELEBRATION, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare central nervous system (CNS) disorders, neurodegenerative diseases, lysosomal storage disorders and related treatment areas, today announced that Richard W. Pascoe, Chief Executive Officer of KemPharm, has issued a Letter to Shareholders.

Key Points: 
  • CELEBRATION, Fla., Jan. 24, 2023 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NasdaqGS: KMPH) (KemPharm, or the Company), a rare disease therapeutics company focused on the development of treatments for rare central nervous system (CNS) disorders, neurodegenerative diseases, lysosomal storage disorders and related treatment areas, today announced that Richard W. Pascoe, Chief Executive Officer of KemPharm, has issued a Letter to Shareholders.
  • KemPharm is a company founded on solid science and this will continue to be a pillar upon which we stand.
  • However, solid science alone will not be enough to propel KemPharm into its next stage of growth and create the value that our shareholders deserve.
  • Our move to rare diseases is an opportunity to build upon what is good at KemPharm and make it great.

Electroactive Polymer Global Market Report 2022: Growing Demand for Electroactive Polymer in Smart Fabrics Fuels Sector - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 19, 2023
Chemicals, Plastics, Manufacturing, EAPS, Electroactive polymers, National Council, Actuator, Textile, Growth, Tissue engineering, Electronics, 3D printing

Global Electroactive Polymer Market is projected to grow at an impressive CAGR during the forecast period due to increase in end use industries.

Key Points: 
  • Global Electroactive Polymer Market is projected to grow at an impressive CAGR during the forecast period due to increase in end use industries.
  • Due to the presence of numerous significant manufacturers, APAC is likely to continue to play an essential role in the electroactive polymer market over the forecast period.
  • Electroactive Polymers (EAPs) are suitable for usage as smart fabrics due to their adaptability and affordability.
  • Remarkable advances in upgrading the actuation strain of Novel Applications such as microfluidic systems and tissue engineering have also emerged, enabling the demand for Actuators resulting in the forecasted growth of the Global Electroactive Polymer Market.

Latest Workplace Mental Well-being Assessment from Infinit Care Calls on Business Leaders to Do Better

Retrieved on: 
Thursday, November 24, 2022
Well, Mental health, Prevalence, Public utility, EAPS, Entrepreneurship, METRO, Business, Clinical Care Classification System, Screen Media (advertising company), Knowledge, Medicine, Risk management

METRO MANILA, Philippines, Nov. 23, 2022 /PRNewswire-PRWeb/ -- From August to September of 2022, Infinit Care, a tech-driven workplace mental well-being platform, conducted the largest cross-industry well-being assessment conducted in the Philippines. The survey covers 2,645 full-time employees across a variety of industries, demographics, and work types, including knowledge and service workers. The assessment was based on the 5-item World Health Organization Well-Being Index (WHO-5), which is one of the most widely used measures of current mental well-being. Participants of the survey self-reported on 5 statements pertaining to their general feelings of well-being in the two weeks prior to taking the assessment. A percentage score of 100 represents the best possible well-being state, and a score below 50 is seen to be indicative of reduced well-being.

Key Points: 
  • Infinit Care, a tech-driven workplace mental well-being platform, conducted the largest cross-industry well-being assessment conducted in the Philippines.
  • Data from the survey shows that business leaders need to do better to support the mental wellbeing of their employees.
  • METRO MANILA, Philippines, Nov. 23, 2022 /PRNewswire-PRWeb/ -- From August to September of 2022, Infinit Care, a tech-driven workplace mental well-being platform, conducted the largest cross-industry well-being assessment conducted in the Philippines.
  • Infinit Care, a tech-driven workplace mental well-being platform, transforms workforces with comprehensive mental well-being.

Stevens Nation Responds to FDA's Refusal to File Letter, NurOwn Recipients Call for Advisory Committee Meeting

Retrieved on: 
Tuesday, November 22, 2022
Authorization, Muscle weakness, CDER, Brainstorm, Therapy, Camping, Atrophy, Eating, Refusal, FDA, Amyotrophic lateral sclerosis, Pulmonology, EAPS, Spinal cord, University of California, Irvine, Expanded access, RTF, UC, Advisory Committee, CDC, Patient, Phase, Aerospace, Walking, Motor neuron, Neurology, Brain, Life expectancy, Letter, Food, Exercise, Disease, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, EAP, Pharmaceutical industry, Medical device, Renewable energy, ALS

WASHINGTON, Nov. 21, 2022 /PRNewswire/ -- Brainstorm Cell Therapeutics is seeking FDA approval of its mesenchymal stem cell therapy called NurOwn for the treatment of ALS. In response to the FDA's Refusal to File letter, and as people who participated in the NurOwn trials and its Expanded Access program ("EAP"), we support Brainstorm's efforts to seek an Advisory Committee ("AdCom") meeting.

Key Points: 
  • In response to the FDA's Refusal to File letter, and as people who participated in the NurOwn trials and its Expanded Access program ("EAP"), we support Brainstorm's efforts to seek an Advisory Committee ("AdCom") meeting.
  • We must insist that the FDA allow testimony about the "clinically meaningful" changes that occurred when we received NurOwn.
  • However, the Phase III trial did meet a pre-specified secondary endpoint in a subgroup of patients with less advanced ALS.
  • The best people to attest to how NurOwn made them "feel and function" are the people who received NurOwn.

Walmart Canada and TELUS Health join forces to provide Walmart associates with comprehensive virtual health and wellbeing services

Retrieved on: 
Thursday, November 10, 2022
People, GLOBE, Pharmacist, Health, Overalls, Regeneration, Walmart Canada, Technology, Medical assistant, Family, Mental health, TELUS, Efficiency, Sexual identity, Exercise, Eating, EAPS, Mindfulness, Ethics, Goal, Solution, Weight loss, Habit, Physician, Associate, Telus Health, Walmart, Medicine, Google

MISSISSAUGA, Ontario and VANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Walmart Canada and TELUS Health announced today a new strategic initiative to bring TELUS Healths full suite of total health and wellbeing solutions to all Walmart associates in Canada.

Key Points: 
  • MISSISSAUGA, Ontario and VANCOUVER, British Columbia, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Walmart Canada and TELUS Health announced today a new strategic initiative to bring TELUS Healths full suite of total health and wellbeing solutions to all Walmart associates in Canada.
  • This robust suite of health services will provide Walmart Canada associates and their families with confidential access to hundreds of health professionals from a variety of disciplines to support every step of their healthcare journey.
  • Were partnering with TELUS Health given their ability to provide a comprehensive wellbeing offering that is inclusive on a simple, digital platform that our associates will benefit from.
  • TELUS Health has more than a decade of experience in virtual care services delivering a national, employer-focused suite of programs that make health and wellness more accessible for associates and their families.